Philippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of…
The Philippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthPhilippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of…
View Premium plansBrowse free archive reportsThe Philippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.